Gevo (GEVO) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $1.17, +0.00% vs the prior close of $1.17.
- Volume 12.94M shares, 4.5x its 50-day average (heavy).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
GEVO ends flat (+0.0%) to $1.17 on 4.5x normal volume. Closed at $1.17, +0.00% vs the prior close of $1.17. Day range $1.16–$1.21, opened at $1.18.
GEVO daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — GEVO ends flat (+0.0%) to $1.17 on 4.5x normal volume
- Closed at $1.17, +0.00% vs the prior close of $1.17. Day range $1.16–$1.21, opened at $1.18.
- Volume was 12.94M shares, 4.5x its 50-day average of 2.85M — unusually heavy trading.
- Price is -21.7% vs its 50-day average ($1.49) and -33.6% vs its 200-day average ($1.76).
- 52-week range $1.15–$2.97; today's close sits at 1% of that range, 60.6% below the 52-week high.
- That makes 3 straight losses.
Oct 15, 2026 — GEVO ends flat (+0.0%) to $1.17
- Closed at $1.17, +0.00% vs the prior close of $1.17. Day range $1.15–$1.20, opened at $1.18.
- Volume was 3.57M shares, 1.3x its 50-day average of 2.84M.
- Price is -22.0% vs its 50-day average ($1.50) and -33.7% vs its 200-day average ($1.77).
- 52-week range $1.15–$2.97; today's close sits at 1% of that range, 60.6% below the 52-week high.
Oct 14, 2026 — GEVO slides 9.3% to $1.17, a 52-week low
- Closed at $1.17, -9.30% vs the prior close of $1.29. Day range $1.17–$1.30, opened at $1.29.
- Volume was 4.87M shares, 1.7x its 50-day average of 2.81M.
- Price is -22.3% vs its 50-day average ($1.51) and -33.9% vs its 200-day average ($1.77).
- 52-week range $1.17–$2.97; today's close sits at 0% of that range, 60.6% below the 52-week high.
Oct 13, 2026 — GEVO rises 0.8% to $1.29
- Closed at $1.29, +0.78% vs the prior close of $1.28. Day range $1.24–$1.30, opened at $1.27.
- Volume was 2.34M shares, 0.8x its 50-day average of 2.81M.
- Price is -14.8% vs its 50-day average ($1.51) and -27.3% vs its 200-day average ($1.77).
- 52-week range $1.24–$2.97; today's close sits at 3% of that range, 56.6% below the 52-week high.
Oct 12, 2026 — GEVO slides 3.0% to $1.28
- Closed at $1.28, -3.03% vs the prior close of $1.32. Day range $1.28–$1.33, opened at $1.31.
- Volume was 2.80M shares, 1.0x its 50-day average of 2.80M.
- Price is -15.6% vs its 50-day average ($1.52) and -28.0% vs its 200-day average ($1.78).
- 52-week range $1.25–$2.97; today's close sits at 2% of that range, 56.9% below the 52-week high.
Oct 9, 2026 — GEVO dips 2.2% to $1.32
- Closed at $1.32, -2.22% vs the prior close of $1.35. Day range $1.32–$1.37, opened at $1.35.
- Volume was 1.93M shares, 0.7x its 50-day average of 2.82M.
- Price is -13.2% vs its 50-day average ($1.52) and -26.0% vs its 200-day average ($1.78).
- 52-week range $1.25–$2.97; today's close sits at 4% of that range, 55.6% below the 52-week high.
Oct 8, 2026 — GEVO jumps 3.8% to $1.35
- Closed at $1.35, +3.85% vs the prior close of $1.30. Day range $1.29–$1.39, opened at $1.30.
- Volume was 4.17M shares, 1.5x its 50-day average of 2.79M.
- Price is -11.5% vs its 50-day average ($1.53) and -24.5% vs its 200-day average ($1.79).
- 52-week range $1.25–$2.97; today's close sits at 6% of that range, 54.5% below the 52-week high.
Oct 7, 2026 — GEVO rises 1.6% to $1.30
- Closed at $1.30, +1.56% vs the prior close of $1.28. Day range $1.25–$1.32, opened at $1.27.
- Volume was 1.98M shares, 0.7x its 50-day average of 2.81M.
- Price is -14.9% vs its 50-day average ($1.53) and -27.4% vs its 200-day average ($1.79).
- 52-week range $1.25–$2.97; today's close sits at 3% of that range, 56.2% below the 52-week high.
Oct 6, 2026 — GEVO dips 0.8% to $1.28, a 52-week low, 10 down days in a row
- Closed at $1.28, -0.78% vs the prior close of $1.29. Day range $1.27–$1.31, opened at $1.29.
- Volume was 2.31M shares, 0.8x its 50-day average of 2.82M.
- Price is -16.4% vs its 50-day average ($1.53) and -28.7% vs its 200-day average ($1.80).
- 52-week range $1.27–$2.97; today's close sits at 1% of that range, 56.9% below the 52-week high.
- That makes 10 straight losses.
Oct 5, 2026 — GEVO dips 1.5% to $1.29, a 52-week low, 9 down days in a row
- Closed at $1.29, -1.53% vs the prior close of $1.31. Day range $1.27–$1.32, opened at $1.30.
- Volume was 2.47M shares, 0.9x its 50-day average of 2.85M.
- Price is -16.1% vs its 50-day average ($1.54) and -28.3% vs its 200-day average ($1.80).
- 52-week range $1.27–$2.97; today's close sits at 1% of that range, 56.6% below the 52-week high.
- That makes 9 straight losses.
Oct 2, 2026 — GEVO dips 0.8% to $1.31, a 52-week low, 8 down days in a row
- Closed at $1.31, -0.76% vs the prior close of $1.32. Day range $1.30–$1.35, opened at $1.34.
- Volume was 1.76M shares, 0.6x its 50-day average of 2.91M.
- Price is -15.2% vs its 50-day average ($1.54) and -27.4% vs its 200-day average ($1.80).
- 52-week range $1.30–$2.97; today's close sits at 1% of that range, 55.9% below the 52-week high.
- That makes 8 straight losses.
GEVO latest news & SEC filings
Every SEC filing by or about GEVO in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 4, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Bowron Kimberly T sold 1,221 shares at $1.71 (≈$2.09K) on Sep 3, 2026
- Bowron Kimberly T sold 1,221 shares at $1.71 (≈$2.09K) on Sep 3, 2026
- Bowron Kimberly T sold 1,221 shares at $1.71 (≈$2.09K) on Sep 3, 2026
- Bowron Kimberly T sold 1,221 shares at $1.71 (≈$2.09K) on Sep 3, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 4, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Bloom Paul D sold 1,514 shares at $1.71 (≈$2.59K) on Sep 3, 2026
- Bloom Paul D sold 1,514 shares at $1.71 (≈$2.59K) on Sep 3, 2026
- Bloom Paul D sold 1,514 shares at $1.71 (≈$2.59K) on Sep 3, 2026
- Bloom Paul D sold 1,514 shares at $1.71 (≈$2.59K) on Sep 3, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 4, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Gruber Patrick R. sold 3,333 shares at $1.70 (≈$5.67K) on Sep 3, 2026
- Gruber Patrick R. sold 3,333 shares at $1.70 (≈$5.67K) on Sep 3, 2026
- Gruber Patrick R. sold 3,333 shares at $1.70 (≈$5.67K) on Sep 3, 2026
- Gruber Patrick R. sold 3,333 shares at $1.70 (≈$5.67K) on Sep 3, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 3, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 3, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 3, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 26, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 7, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 6, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $46.50M (prior year $43.41M) (+7.1% vs Jun 30, 2025)
- Net income: -$176.94M (prior year $2.14M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.75 (prior year $0.01) (loss widened vs Jun 30, 2025)
Aug 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 16, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Jul 15, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Things to know before you trade GEVO
- Last results release: Aug 6, 2026 (8-K Item 2.02). Previous ones: May 7, 2026, Mar 5, 2026, Nov 10, 2025. Based on that rhythm, the next report is likely around Nov 5, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.16% (largest 9.3%).
- Liquidity: about 3.34M shares (≈$3.91M) trade per day on average.
- 52-week position: $1.17 vs a range of $1.15–$2.97 (1% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 8 open-market buys, 17 sales; latest: Kimberly T Bowron sold 1,221 shares on Sep 3, 2026.
- Latest filings: 8-K Aug 26, 2026; 10-Q Aug 6, 2026; 8-K Aug 6, 2026.
- Share count: 247.24M shares outstanding (Aug 5, 2026), +2.2% vs a year earlier.
- Listing: Nasdaq · industry: Industrial Organic Chemicals.
GEVO market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.18 | 1.21 | 1.16 | 1.17 | 12.94M |
| Oct 15, 2026 | 1.18 | 1.20 | 1.15 | 1.17 | 3.57M |
| Oct 14, 2026 | 1.29 | 1.30 | 1.17 | 1.17 | 4.87M |
| Oct 13, 2026 | 1.27 | 1.30 | 1.24 | 1.29 | 2.34M |
| Oct 12, 2026 | 1.31 | 1.33 | 1.28 | 1.28 | 2.80M |
| Oct 9, 2026 | 1.35 | 1.37 | 1.32 | 1.32 | 1.93M |
| Oct 8, 2026 | 1.30 | 1.39 | 1.29 | 1.35 | 4.17M |
| Oct 7, 2026 | 1.27 | 1.32 | 1.25 | 1.30 | 1.98M |
| Oct 6, 2026 | 1.29 | 1.31 | 1.27 | 1.28 | 2.31M |
| Oct 5, 2026 | 1.30 | 1.32 | 1.27 | 1.29 | 2.47M |
| Oct 2, 2026 | 1.34 | 1.35 | 1.30 | 1.31 | 1.76M |
| Oct 1, 2026 | 1.32 | 1.35 | 1.31 | 1.32 | 2.03M |
| Sep 30, 2026 | 1.34 | 1.35 | 1.31 | 1.32 | 2.74M |
| Sep 29, 2026 | 1.35 | 1.37 | 1.32 | 1.33 | 3.74M |
| Sep 28, 2026 | 1.42 | 1.42 | 1.33 | 1.34 | 2.88M |
| Sep 25, 2026 | 1.41 | 1.43 | 1.38 | 1.40 | 2.40M |
| Sep 24, 2026 | 1.46 | 1.47 | 1.39 | 1.40 | 3.10M |
| Sep 23, 2026 | 1.54 | 1.56 | 1.45 | 1.45 | 3.38M |
| Sep 22, 2026 | 1.53 | 1.58 | 1.53 | 1.56 | 2.08M |
| Sep 21, 2026 | 1.54 | 1.59 | 1.52 | 1.54 | 3.35M |
About Gevo
Gevo (GEVO) is listed on the Nasdaq and classified by the SEC under “Industrial Organic Chemicals”. Its business address is in ENGLEWOOD, CO. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1392380.
GEVO board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Angelo Amorelli | Director | Oct 15, 2025 |
| William H Baum | Director | May 29, 2026 |
| James J Barber | Director | Aug 24, 2026 |
| Carol Jane Battershell | Director | Nov 14, 2025 |
| Paul D Bloom | CEO | Sep 4, 2026 |
| Mary Kathryn Ellet | Director | May 29, 2026 |
| Patrick R. Gruber | Director | Sep 4, 2026 |
| Jaime Guillen | Director | May 29, 2026 |
| Andrew Marsh | Director | May 29, 2026 |
| Gary W. Mize | Director | May 29, 2026 |
| Todd Allen Werpy | Director | Aug 24, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Oluwagbemileke Yusuf Agiri | CFO | Aug 7, 2026 |
| Paul D Bloom | CEO | Sep 4, 2026 |
| Kimberly T Bowron | Chief of Staff | Sep 4, 2026 |
| Lindsay Clinton Fitzgerald | Chief Advocacy Officer | May 22, 2026 |
| Davaajargal Gendenjamts | VP Acctg and Treasurer | Jun 15, 2026 |
| Greg Edwin Hanselman | COO | Aug 26, 2026 |
| Kyle Dean James | Chief Commercial Officer | May 22, 2026 |
| David Michael Kettner | Chief Legal & Emrg Biz Officer | Aug 24, 2026 |
| Christopher Michael Ryan | President & COO | Jun 15, 2026 |
| Andrew Shafer | Chief Mktg Cust & Brnd Officer | Jun 15, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 3, 2026 | Kimberly T Bowron | Sale | 1,221 | $1.71 |
| Sep 3, 2026 | Kimberly T Bowron | Sale | 1,221 | $1.71 |
| Sep 3, 2026 | Kimberly T Bowron | Sale | 1,221 | $1.71 |
| Sep 3, 2026 | Kimberly T Bowron | Sale | 1,221 | $1.71 |
| Sep 3, 2026 | Patrick R. Gruber | Sale | 3,333 | $1.70 |
| Sep 3, 2026 | Patrick R. Gruber | Sale | 3,333 | $1.70 |
| Sep 3, 2026 | Patrick R. Gruber | Sale | 3,333 | $1.70 |
| Sep 3, 2026 | Patrick R. Gruber | Sale | 3,333 | $1.70 |
| Sep 3, 2026 | Paul D Bloom | Sale | 1,514 | $1.71 |
| Sep 3, 2026 | Paul D Bloom | Sale | 1,514 | $1.71 |
| Sep 3, 2026 | Paul D Bloom | Sale | 1,514 | $1.71 |
| Sep 3, 2026 | Paul D Bloom | Sale | 1,514 | $1.71 |
| Aug 21, 2026 | James J Barber | Buy | 50,000 | $1.54 |
| Aug 21, 2026 | James J Barber | Buy | 50,000 | $1.54 |
| Aug 21, 2026 | James J Barber | Buy | 50,000 | $1.54 |
GEVO financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $160.58M | $-33.84M | -0.14 | $-13.40M |
| Dec 31, 2024 | $16.91M | $-78.64M | -0.34 | $-57.38M |
| Dec 31, 2023 | $17.20M | $-66.22M | -0.28 | $-53.72M |
| Dec 31, 2022 | $1.18M | $-98.01M | -0.44 | $-44.31M |
| Dec 31, 2021 | $533.00K | $-59.20M | -0.30 | $-48.27M |
Latest balance sheet: total assets $490.71M, total liabilities $209.76M, cash $58.15M (as of Jun 30, 2026).
GEVO earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 6, 2026 | 8-K Item 2.02 (results) | $1.44 |
| May 7, 2026 | 8-K Item 2.02 (results) | $2.03 |
| Mar 5, 2026 | 8-K Item 2.02 (results) | $1.89 |
| Nov 10, 2025 | 8-K Item 2.02 (results) | $2.12 |
| Aug 11, 2025 | 8-K Item 2.02 (results) | $1.25 |
| May 13, 2025 | 8-K Item 2.02 (results) | $1.24 |
| Mar 27, 2025 | 8-K Item 2.02 (results) | $1.26 |
| Nov 7, 2024 | 8-K Item 2.02 (results) | $1.90 |
| Aug 8, 2024 | 8-K Item 2.02 (results) | — |
| May 2, 2024 | 8-K Item 2.02 (results) | — |
| Mar 7, 2024 | 8-K Item 2.02 (results) | — |
| Jan 24, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Industrial Organic Chemicals
LyondellBasell Industries (LYB)International Flavors & Fragrances (IFF)Newmarket (NEU)Westlake (WLK)Sensient Technologies (SXT)Methanex (MEOH)Green Plains (GPRE)Rex American Resources (REX)Alto Ingredients (ALTO)Comstock (LODE)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on GEVO
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.